What does PHARMACIE MERTENS do?

PHARMACIE MERTENS is a logistics company in Estaimpuis. Private Limited, started on 18 February 2005, 1 establishment.

What is the address of PHARMACIE MERTENS?

The registered office of PHARMACIE MERTENS is located at Rue Saint-Brice(B) 28A, 7730 Estaimpuis.

Is PHARMACIE MERTENS still active?

Yes. According to the CBE (30 October 2026) PHARMACIE MERTENS is active, legal situation “Normale toestand”, started on 18 February 2005.

Is PHARMACIE MERTENS registered on Peppol?

Yes, PHARMACIE MERTENS is registered on the Peppol network with ID 0208:0871980708.

What is the enterprise number of PHARMACIE MERTENS?

The enterprise number of PHARMACIE MERTENS is BE0871980708.

When was PHARMACIE MERTENS founded?

PHARMACIE MERTENS was founded on 18 February 2005.

Who are the directors of PHARMACIE MERTENS?

According to the 2025 annual accounts, the directors of PHARMACIE MERTENS are: ISABELLE MERTENS.

Is PHARMACIE MERTENS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 February 2005; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE MERTENS make in 2025?

PHARMACIE MERTENS posted a profit after taxes of € 68,939 in financial year 2025.

What is the revenue of PHARMACIE MERTENS?

As a small company, PHARMACIE MERTENS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 369,729.

How much does an employee at PHARMACIE MERTENS earn?

The average wage cost per full-time employee at PHARMACIE MERTENS was € 80,900 in 2025: staff costs of € 234,705 for 2.9 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE MERTENS have?

According to the 2025 annual accounts, PHARMACIE MERTENS has 2.9 full-time equivalents (FTE).

PHARMACIE MERTENS (Private Limited) - Estaimpuis

Dossier PHARMACIE MERTENS, printed on 30 October 2026 from databakkes.be/en/0871980708/pharmacie-mertens. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 3.7 to 2.9.

Financials

Financial year 2025

PHARMACIE MERTENS from Estaimpuis, company number BE0871980708, closed financial year 2025 with a result of € 68,939 after tax. For that financial year PHARMACIE MERTENS recorded a gross margin of € 369,729 and equity of € 416,343. Compared with financial year 2024, the result moved from € 66,442 to € 68,939. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.

What it is worth Growing

€ 416,343

▲ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 68,939

▲ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 242,241

▲ 7% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 48,000 paid out

70 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

2.9

▼ 0.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 234,705

▼ 9% vs 2024

€ 80,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,206

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 90,935

▼ 30% vs 2024

€ 23,269 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 43,771

▼ 34% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 53,372

▼ 9% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 375,530 Gross margin 2022: € 375,530 First fiscal year in the series	€ 329,961 Gross margin 2023: € 329,961 ▼ 12% vs 2022 (€ 375,530) Unfavourable step	€ 389,337 Gross margin 2024: € 389,337 ▲ 18% vs 2023 (€ 329,961) Favourable step	€ 369,729 Gross margin 2025: € 369,729 ▼ 5% vs 2024 (€ 389,337) Unfavourable step	▼ 5%
Profit after taxes	€ 52,699 Profit after taxes 2022: € 52,699 First fiscal year in the series	€ 6,836 Profit after taxes 2023: € 6,836 ▼ 87% vs 2022 (€ 52,699) Unfavourable step	€ 66,442 Profit after taxes 2024: € 66,442 ▲ € 59,606 vs 2023 (€ 6,836) Favourable step	€ 68,939 Profit after taxes 2025: € 68,939 ▲ 4% vs 2024 (€ 66,442) Favourable step	▲ 4%
Equity	€ 422,627 Equity 2022: € 422,627 First fiscal year in the series	€ 355,463 Equity 2023: € 355,463 ▼ 16% vs 2022 (€ 422,627) Unfavourable step	€ 395,404 Equity 2024: € 395,404 ▲ 11% vs 2023 (€ 355,463) Favourable step	€ 416,343 Equity 2025: € 416,343 ▲ 5% vs 2024 (€ 395,404) Favourable step	▲ 5%
Total debts	€ 394,377 Total debts 2022: € 394,377 First fiscal year in the series	€ 430,924 Total debts 2023: € 430,924 ▲ 9% vs 2022 (€ 394,377) Unfavourable step	€ 407,843 Total debts 2024: € 407,843 ▼ 5% vs 2023 (€ 430,924) Favourable step	€ 320,090 Total debts 2025: € 320,090 ▼ 22% vs 2024 (€ 407,843) Favourable step	▼ 22%
Cash	€ 205,759 Cash 2022: € 205,759 First fiscal year in the series	€ 153,957 Cash 2023: € 153,957 ▼ 25% vs 2022 (€ 205,759) Unfavourable step	€ 226,863 Cash 2024: € 226,863 ▲ 47% vs 2023 (€ 153,957) Favourable step	€ 242,241 Cash 2025: € 242,241 ▲ 7% vs 2024 (€ 226,863) Favourable step	▲ 7%
Land & buildings	€ 248,915 Land & buildings 2022: € 248,915 First fiscal year in the series	€ 263,308 Land & buildings 2023: € 263,308 ▲ 6% vs 2022 (€ 248,915) Unchanged	€ 240,765 Land & buildings 2024: € 240,765 ▼ 9% vs 2023 (€ 263,308) Unchanged	€ 217,699 Land & buildings 2025: € 217,699 ▼ 10% vs 2024 (€ 240,765) Unchanged	▼ 10%
Retained profit	€ 410,227 Retained profit 2022: € 410,227 First fiscal year in the series	€ 343,063 Retained profit 2023: € 343,063 ▼ 16% vs 2022 (€ 410,227) Unfavourable step	€ 383,004 Retained profit 2024: € 383,004 ▲ 12% vs 2023 (€ 343,063) Favourable step	€ 403,943 Retained profit 2025: € 403,943 ▲ 5% vs 2024 (€ 383,004) Favourable step	▲ 5%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 74,000 Dividend 2023: € 74,000 Unchanged (€ 0) Unchanged	€ 26,500 Dividend 2024: € 26,500 ▼ 64% vs 2023 (€ 74,000) Unchanged	€ 48,000 Dividend 2025: € 48,000 ▲ 81% vs 2024 (€ 26,500) Unchanged	▲ 81%
Bank debt	€ 217,246 Bank debt 2022: € 217,246 First fiscal year in the series	€ 171,939 Bank debt 2023: € 171,939 ▼ 21% vs 2022 (€ 217,246) Favourable step	€ 130,436 Bank debt 2024: € 130,436 ▼ 24% vs 2023 (€ 171,939) Favourable step	€ 90,935 Bank debt 2025: € 90,935 ▼ 30% vs 2024 (€ 130,436) Favourable step	▼ 30%
Balance sheet total	€ 817,004 Balance sheet total 2022: € 817,004 First fiscal year in the series	€ 786,386 Balance sheet total 2023: € 786,386 ▼ 4% vs 2022 (€ 817,004) Unchanged	€ 803,247 Balance sheet total 2024: € 803,247 ▲ 2% vs 2023 (€ 786,386) Unchanged	€ 736,434 Balance sheet total 2025: € 736,434 ▼ 8% vs 2024 (€ 803,247) Unchanged	▼ 8%
Employees (FTE)	3.7 Employees (FTE) 2022: 3.7 First fiscal year in the series	3.7 Employees (FTE) 2023: 3.7 Unchanged (3.7) Unchanged	3.5 Employees (FTE) 2024: 3.5 ▼ 0.2 vs 2023 (3.7) Unchanged	2.9 Employees (FTE) 2025: 2.9 ▼ 0.6 vs 2024 (3.5) Unchanged	▼ 0.6

Key figures of PHARMACIE MERTENS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE MERTENS?

What happened at PHARMACIE MERTENS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 26, 2026 New annual accounts for financial year 2025: profit of € 68,939 (▲ 4% vs 2024). filed late Source: NBB ↗
Mar 23, 2005 New establishment in Estaimpuis. KBO
2005 ISABELLE MERTENS became a director. NBB
Feb 18, 2005 Start of the company according to the CBE. KBO

In short

From € 52,699 profit in 2022 to € 68,939 profit in 2025.

Paid € 78,060 in corporate taxes since 2022.

Best year ever: 2025, with € 68,939 profit.

On average € 127,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

ISABELLE MERTENS

PHARMACIE MERTENS

Behind PHARMACIE MERTENS is ISABELLE MERTENS.

Directors

According to the 2025 annual accounts

ISABELLE MERTENS

Director

since 2005

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Saint-Brice(B) 28A

7730 Estaimpuis

2.145.850.034

Rue Saint-Brice(B) 28 box A

7730 Estaimpuis

Active since 23 March 2005

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0871.980.708

VAT number

BE 0871.980.708

Registered office

Rue Saint-Brice(B) 28A, 7730 Estaimpuis

Names & denominations

PHARMACIE MERTENS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

18 February 2005

Peppol

Active · Active since 17 Dec 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE MERTENS

Warning lights

Financials

What happened to PHARMACIE MERTENS?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions